International Study Links Ambient PM2.5 Exposure to Lower Clinical Pregnancy and Live-Birth Rates Following Assisted Reproductive Technology.

  • Post author:
  • Post category:Sales & Growth

Research presented by Taipei American School student Jeffrey Zi Kang Huang at ESHRE 2026 through an international collaboration among Taiwan IVF Group, Ton Yen General Hospital, and Stanford University.LONDON, July 29, 2026 /PRNewswire/ -- An international study examining…

Continue ReadingInternational Study Links Ambient PM2.5 Exposure to Lower Clinical Pregnancy and Live-Birth Rates Following Assisted Reproductive Technology.

Net Health Introduces Agentic Documentation to Outpatient and Hospital-Based Rehab Therapy

  • Post author:
  • Post category:Sales & Growth

Native ambient scribe based on actual documentation of clinicians across physical therapy, occupational therapy, and speech-language pathology; reduces documentation time by up to 20 minutesPITTSBURGH, July 28, 2026 /PRNewswire/ -- Net Health, an AI-native specialty platform serving clinicians…

Continue ReadingNet Health Introduces Agentic Documentation to Outpatient and Hospital-Based Rehab Therapy

Icarus Wellness and Recovery Names Mallory Harris as Executive Director

  • Post author:
  • Post category:Sales & Growth

Behavioral health leader brings more than 12 years of experience developing client-centered treatment programs for substance use, eating disorders and complex mental health conditionsBOISE, Idaho, July 28, 2026 /PRNewswire/ -- Icarus Wellness and Recovery announced Mallory Harris, MBA,…

Continue ReadingIcarus Wellness and Recovery Names Mallory Harris as Executive Director

Vector Science & Therapeutics Corp., LyoGenesis Plus and Wynn Pharmaceuticals Announce Strategic Collaboration to Develop and Manufacture Critical Care Medical Products

  • Post author:
  • Post category:Sales & Growth

MEQUON, Wis. and LENEXA, Kan., July 28, 2026 /PRNewswire/ -- LyoGenesis Plus 1, LLC ("LyoGenesis Plus"), a company related to Vector Science & Therapeutics Corp. ("Vector"), and Wynn Pharmaceuticals LLC ("Wynn") today announced they have entered into a…

Continue ReadingVector Science & Therapeutics Corp., LyoGenesis Plus and Wynn Pharmaceuticals Announce Strategic Collaboration to Develop and Manufacture Critical Care Medical Products

Why Consumers Are Exploring PureHealth Research Optimal Health Supplements for Everyday Wellness

  • Post author:
  • Post category:Sales & Growth

MANASSAS, Va., July 25, 2026 /PRNewswire/ -- Proactive wellness has become one of the most talked-about themes in health circles – and daily nutritional support is a big part of why. PureHealth Research optimal health supplements, built around a blend…

Continue ReadingWhy Consumers Are Exploring PureHealth Research Optimal Health Supplements for Everyday Wellness

Laminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients

  • Post author:
  • Post category:Sales & Growth

PALMA DE MALLORCA, Spain, July 23, 2026 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV)…

Continue ReadingLaminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients

Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy

  • Post author:
  • Post category:Sales & Growth

The U.S. FDA has granted Fast Track designation to Lu AH69593, an oral orexin 2 receptor agonist, for the treatment of patients with narcolepsyThe orexin 2 receptor is critically located in the main biological pathway involved in wakefulness…

Continue ReadingLundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy

GHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB

  • Post author:
  • Post category:Sales & Growth

TOKYO, July 23, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of JPY 140 million (approximately USD 862,000) in a project to develop a portable rapid diagnostic system for Ebola disease. The…

Continue ReadingGHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB

Pacific Mind Health Offers Ketamine Therapy for Depression That Follows Overwhelming Grief

  • Post author:
  • Post category:Sales & Growth

LOS ANGELES, July 22, 2026 /PRNewswire/ -- Pacific Mind Health, a behavioral health care organization based in Southern California, today announced ketamine therapy for patients whose grief has developed into persistent depression. Grief is a normal response to…

Continue ReadingPacific Mind Health Offers Ketamine Therapy for Depression That Follows Overwhelming Grief